Surgical site infections

Surgical Clinics of North America

Volumn 94, Issue 6, 2014, Pages 1245-1264

  Young, Pang Y ^a   Khadaroo, Rachel G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antibiotic prophylaxis; Infection control; Postoperative complication; Surgical site infection; Surgical wound infections

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIAL GROWTH; ECONOMIC ASPECT; EPIDEMIOLOGY; FOLLOW UP; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL DISCHARGE; HUMAN; INCISION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LENGTH OF STAY; MORBIDITY; OXYGEN THERAPY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN DECONTAMINATION; SKIN FLORA; SURGICAL DRAINAGE; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL RISK; WOUND CARE; CROSS INFECTION; PATIENT SAFETY; PROCEDURES; SURGICAL WOUND INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CROSS INFECTION; HUMANS; INFECTION CONTROL; PATIENT SAFETY; PERIOPERATIVE CARE; QUALITY INDICATORS, HEALTH CARE; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 84923814483     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2014.08.008     Document Type: Review

References (107)

1. Newsom S. Pioneers in infection control-Joseph Lister. JHosp Infect 2003, 55(4):246-253.
2. Blaisdell F.W. Medical advances during the Civil War. Arch Surg 1988, 123(9):1045.
3. Manring M.M., Hawk A., Calhoun J.H., et al. Treatment of war wounds: a historical review. Clin Orthop 2009, 467(8):2168-2191.
4. Horan T.C., Gaynes R.P., Martone W.J., et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992, 20(5):271-274.
5. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Am J Infect Control 1999, 27(2):97-134.
6. Nespoli A., Geroulanos S., Nardone A., et al. The history of surgical infections. Surg Infect (Larchmt) 2011, 12(1):3-13.
7. Klevens R.M., Edwards J.R., Richards C.L., et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007, 122(2):160-166.
8. Cruse P.J., Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980, 60(1):27-40.
9. DiPiro J.T., Martindale R.G., Bakst A., et al. Infection in surgical patients: effects on mortality, hospitalization, and postdischarge care. Am J Health Syst Pharm 1998, 55(8):777-781.
10. Rosenthal V.D., Richtmann R., Singh S., et al. Surgical site infections, International Nosocomial Infection Control Consortium (INICC) report, data summary of 30 countries, 2005-2010. Infect Control Hosp Epidemiol 2013, 34(6):597-604.
11. Culver D.H., Horan T.C., Gaynes R.P., et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med 1991, 91(3B):152S-157S.
12. Sievert D.M., Ricks P., Edwards J.R., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013, 34(1):1-14.
13. Hidron A.I., Edwards J.R., Patel J., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008, 29(11):996-1011.
14. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996: A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996, 24(5):380-388.
15. Jernigan J.A. Is the burden of Staphylococcus aureus among patients with surgical-site infections growing?. Infect Control Hosp Epidemiol 2004, 25(6):457-460.
16. Anderson D.J., Sexton D.J., Kanafani Z.A., et al. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007, 28(9):1047-1053.
17. Takesue Y., Watanabe A., Hanaki H., et al. Nationwide surveillance of antimicrobial susceptibility patterns of pathogens isolated from surgical site infections (SSI) in Japan. JInfect Chemother 2012, 18(6):816-826.
18. Gorwitz R.J., Kruszon-Moran D., McAllister S.K., et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. JInfect Dis 2008, 197(9):1226-1234.
19. Kalra L., Camacho F., Whitener C.J., et al. Risk of methicillin-resistant Staphylococcus aureus surgical site infection in patients with nasal MRSA colonization. Am J Infect Control 2013, 41(12):1253-1257.
20. Wang G., Hindler J.F., Ward K.W., et al. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. JClin Microbiol 2006, 44(11):3883-3886.
21. Steinkraus G., White R., Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. JAntimicrob Chemother 2007, 60(4):788-794.
22. Adam H.J., Louie L., Watt C., et al. Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006. Antimicrob Agents Chemother 2010, 54(2):945-949.
23. Reynolds R., Hope R., Warner M., et al. Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07. JAntimicrob Chemother 2012, 67(12):2912-2918.
24. Sader H.S., Fey P.D., Limaye A.P., et al. Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. Antimicrob Agents Chemother 2009, 53(10):4127-4132.
25. van Hal S.J., Paterson D.L. Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates. Antimicrob Agents Chemother 2011, 55(1):405-410.
26. Engemann J.J., Carmeli Y., Cosgrove S.E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003, 36(5):592-598.
27. van Hal S.J., Fowler V.G. Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?. Clin Infect Dis 2013, 56(12):1779-1788.
28. Yong D., Toleman M.A., Giske C.G., et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009, 53(12):5046-5054.
29. Kumarasamy K.K., Toleman M.A., Walsh T.R., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10(9):597-602.
30. Hardy E.J., Mermel L.A., Chapin K.C., et al. Carbapenem-resistant Enterobacteriaceae containing New Delhi metallo-beta-lactamase in two patients - Rhode Island, March 2012. MMWR Morb Mortal Wkly Rep 2012, 61(24):446-448.
31. Mulvey M.R., Grant J.M., Plewes K., et al. New Delhi metallo-beta-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis 2011, 17(1):103-106.
32. Poirel L., Lagrutta E., Taylor P., et al. Emergence of metallo-beta-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010, 54(11):4914-4916.
33. Zhou G., Guo S., Luo Y., et al. NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China. Emerg Infect Dis 2014, 20(2):340-342.
34. Barantsevich E.P., Churkina I.V., Barantsevich N.E., et al. Emergence of Klebsiella pneumoniae producing NDM-1 carbapenemase in Saint Petersburg, Russia. JAntimicrob Chemother 2013, 68(5):1204-1206.
35. Göttig S., Pfeifer Y., Wichelhaus T.A., et al. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect Dis 2010, 10(12):828-829.
36. Nordmann P., Naas T., Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011, 17(10):1791-1798.
37. Morowitz M.J., Babrowski T., Carlisle E.M., et al. The human microbiome and surgical disease. Ann Surg 2011, 253(6):1094-1101.
38. Frank D.N., St Amand A.L., Feldman R.A., et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007, 104(34):13780-13785.
39. Seksik P., Rigottier-Gois L., Gramet G., et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003, 52(2):237-242.
40. Olivas A.D., Shogan B.D., Valuckaite V., et al. Intestinal tissues induce an SNP mutation in Pseudomonas aeruginosa that enhances its virulence: possible role in anastomotic leak. PLoS One 2012, 7(8):e44326.
41. Mangram A.J., Horan T.C., Pearson M.L., et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999, 20(4):250-278. [quiz: 279-80].
42. Neumayer L., Hosokawa P., Itani K., et al. Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. JAm Coll Surg 2007, 204(6):1178-1187.
43. Watanabe A., Kohnoe S., Shimabukuro R., et al. Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Surg Today 2008, 38(5):404-412.
44. Alexander J.W., Solomkin J.S., Edwards M.J. Updated recommendations for control of surgical site infections. Ann Surg 2011, 253(6):1082-1093.
45. Anderson D.J., Kaye K.S., Classen D., et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008, 29(Suppl 1):S51-S61.
46. Furnary A.P., Zerr K.J., Grunkemeier G.L., et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999, 67(2):352-360. [discussion: 360-2].
47. Latham R., Lancaster A.D., Covington J.F., et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001, 22(10):607-612.
48. Zerr K.J., Furnary A.P., Grunkemeier G.L., et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997, 63(2):356-361.
49. Dronge A.S., Perkal M.F., Kancir S., et al. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006, 141(4):375-380. [discussion: 380].
50. Møller A.M., Villebro N., Pedersen T., et al. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002, 359(9301):114-117.
51. Lindstrom D., Sadr Azodi O., Wladis A., et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 2008, 248(5):739-745.
52. Thomsen T., Tonnesen H., Moller A.M. Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation. Br J Surg 2009, 96(5):451-461.
53. Lee I., Agarwal R.K., Lee B.Y., et al. Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol 2010, 31(12):1219-1229.
54. Darouiche R.O., Wall M.J., Itani K.M., et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. NEngl J Med 2010, 362(1):18-26.
55. Paocharoen V., Mingmalairak C., Apisarnthanarak A. Comparison of surgical wound infection after preoperative skin preparation with 4% chlorhexidine [correction of chlohexidine] and povidone iodine: a prospective randomized trial. JMed Assoc Thai 2009, 92(7):898-902.
56. Brown T.R., Ehrlich C.E., Stehman F.B., et al. Aclinical evaluation of chlorhexidine gluconate spray as compared with iodophor scrub for preoperative skin preparation. Surg Gynecol Obstet 1984, 158(4):363-366.
57. Swenson B.R., Hedrick T.L., Metzger R., et al. Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol 2009, 30(10):964-971.
58. Hakkarainen T.W., Dellinger E.P., Evans H.L., et al. Comparative effectiveness of skin antiseptic agents in reducing surgical site infections: a report from the Washington State Surgical Care and Outcomes Assessment Program. J Am Coll Surg 2014, 218(3):336-344.
59. Tschudin-Sutter S., Frei R., Egli-Gany D., et al. No risk of surgical site infections from residual bacteria after disinfection with povidone-iodine-alcohol in 1014 cases: a prospective observational study. Ann Surg 2012, 255(3):565-569.
60. Polk H.C., Lopez-Mayor J.F. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery 1969, 66(1):97-103.
61. Stone H.H., Hooper C.A., Kolb L.D., et al. Antibiotic prophylaxis in gastric, biliary and colonic surgery. Ann Surg 1976, 184(4):443-452.
62. Barie P.S., Eachempati S.R. Surgical site infections. Surg Clin North Am 2005, 85(6):1115-1135. viii-ix.
63. Bratzler D.W., Dellinger E.P., Olsen K.M., et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013, 70(3):195-283.
64. Bratzler D.W., Houck P.M., Surgical Infection Prevention Guideline Writers Workgroup Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005, 189(4):395-404.
65. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm 1999, 56(18):1839-1888.
66. Bowater R.J., Stirling S.A., Lilford R.J. Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses. Ann Surg 2009, 249(4):551-556.
67. Classen D.C., Evans R.S., Pestotnik S.L., et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. NEngl J Med 1992, 326(5):281-286.
68. Garey K.W., Dao T., Chen H., et al. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. JAntimicrob Chemother 2006, 58(3):645-650.
69. Steinberg J.P., Braun B.I., Hellinger W.C., et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg 2009, 250(1):10-16.
70. van Kasteren M.E., Mannien J., Ott A., et al. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis 2007, 44(7):921-927.
71. Forse R.A., Karam B., MacLean L.D., et al. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989, 106(4):750-756. [discussion: 756-7].
72. Zelenitsky S.A., Ariano R.E., Harding G.K., et al. Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother 2002, 46(9):3026-3030.
73. Morita S., Nishisho I., Nomura T., et al. The significance of the intraoperative repeated dosing of antimicrobials for preventing surgical wound infection in colorectal surgery. Surg Today 2005, 35(9):732-738.
74. Bennett-Guerrero E., Ferguson T.B., Lin M., et al. Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA 2010, 304(7):755-762.
75. Eklund A.M., Valtonen M., Werkkala K.A. Prophylaxis of sternal wound infections with gentamicin-collagen implant: randomized controlled study in cardiac surgery. JHosp Infect 2005, 59(2):108-112.
76. Friberg O., Svedjeholm R., Soderquist B., et al. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg 2005, 79(1):153-161. [discussion: 161-2].
77. Schimmer C., Ozkur M., Sinha B., et al. Gentamicin-collagen sponge reduces sternal wound complications after heart surgery: a controlled, prospectively randomized, double-blind study. JThorac Cardiovasc Surg 2012, 143(1):194-200.
78. Mavros M.N., Mitsikostas P.K., Alexiou V.G., et al. Gentamicin collagen sponges for the prevention of sternal wound infection: a meta-analysis of randomized controlled trials. JThorac Cardiovasc Surg 2012, 144(5):1235-1240.
79. Bennett-Guerrero E., Pappas T.N., Koltun W.A., et al. Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery. NEngl J Med 2010, 363(11):1038-1049.
80. Alexander J.W., Rahn R., Goodman H.R. Prevention of surgical site infections by an infusion of topical antibiotics in morbidly obese patients. Surg Infect (Larchmt) 2009, 10(1):53-57.
81. Greif R., Akca O., Horn E.P., et al. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. NEngl J Med 2000, 342(3):161-167.
82. Belda F.J., Aguilera L., Garcia de la Asuncion J., et al. Supplemental perioperative oxygen and the risk of surgical wound infection: a randomized controlled trial. JAMA 2005, 294(16):2035-2042.
83. Meyhoff C.S., Wetterslev J., Jorgensen L.N., et al. Effect of high perioperative oxygen fraction on surgical site infection and pulmonary complications after abdominal surgery: the PROXI randomized clinical trial. JAMA 2009, 302(14):1543-1550.
84. Pryor K.O., Fahey T.J., Lien C.A., et al. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA 2004, 291(1):79-87.
85. Meyhoff C.S., Jorgensen L.N., Wetterslev J., et al. Increased long-term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow-up of a randomized clinical trial. Anesth Analg 2012, 115(4):849-854.
86. Hovaguimian F., Lysakowski C., Elia N., et al. Effect of intraoperative high inspired oxygen fraction on surgical site infection, postoperative nausea and vomiting, and pulmonary function: systematic review and meta-analysis of randomized controlled trials. Anesthesiology 2013, 119(2):303-316.
87. Qadan M., Akca O., Mahid S.S., et al. Perioperative supplemental oxygen therapy and surgical site infection: a meta-analysis of randomized controlled trials. Arch Surg 2009, 144(4):359-366. [discussion: 366-7].
88. Chura J.C., Boyd A., Argenta P.A. Surgical site infections and supplemental perioperative oxygen in colorectal surgery patients: a systematic review. Surg Infect (Larchmt) 2007, 8(4):455-461.
89. Kurz A., Sessler D.I., Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. NEngl J Med 1996, 334(19):1209-1215.
90. Walz J.M., Paterson C.A., Seligowski J.M., et al. Surgical site infection following bowel surgery: a retrospective analysis of 1446 patients. Arch Surg 2006, 141(10):1014-1018. [discussion: 1018].
91. Bratzler D.W., Hunt D.R. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006, 43(3):322-330.
92. Tanner J., Woodings D., Moncaster K. Preoperative hair removal to reduce surgical site infection. Cochrane Database Syst Rev 2006, (3). CD004122.
93. Eskicioglu C., Gagliardi A.R., Fenech D.S., et al. Surgical site infection prevention: a survey to identify the gap between evidence and practice in University of Toronto teaching hospitals. Can J Surg 2012, 55(4):233-238.
94. Larochelle M., Hyman N., Gruppi L., et al. Diminishing surgical site infections after colorectal surgery with surgical care improvement project: is it time to move on?. Dis Colon Rectum 2011, 54(4):394-400.
95. Kirby J.P., Mazuski J.E. Prevention of surgical site infection. Surg Clin North Am 2009, 89(2):365-389. viii.
96. Nichols R.L., Florman S. Clinical presentations of soft-tissue infections and surgical site infections. Clin Infect Dis 2001, 33(Suppl 2):S84-S93.
97. Stevens D.L., Bisno A.L., Chambers H.F., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41(10):1373-1406.
98. Fry D.E. The economic costs of surgical site infection. Surg Infect (Larchmt) 2002, 3(s1):s37-s43.
99. Zoutman D., McDonald S., Vethanayagan D. Total and attributable costs of surgical-wound infections at a Canadian tertiary-care center. Infect Control Hosp Epidemiol 1998, 19(4):254-259.
100. Whitehouse J.D., Friedman N.D., Kirkland K.B., et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002, 23(4):183-189.
101. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29(7):1303-1310.
102. Awad S.S. Adherence to surgical care improvement project measures and post-operative surgical site infections. Surg Infect (Larchmt) 2012, 13(4):234-237.
103. Fact sheet: CMS final rule to improve quality of care during hospital inpatient stays. 2013. Available at: Accessed March 9, 2014. http://www.cms.gov/newsroom/mediareleasedatabase/fact-sheets/2013-fact-sheets-items/2013-08-02-3.html.
104. Cataife G., Weinberg D.A., Wong H.H., et al. The effect of Surgical Care Improvement Project (SCIP) compliance on surgical site infections (SSI). Med Care 2014, 52(2 Suppl 1):S66-S73.
105. Stulberg J.J., Delaney C.P., Neuhauser D.V., et al. Adherence to surgical care improvement project measures and the association with postoperative infections. JAMA 2010, 303(24):2479-2485.
106. Hawn M.T., Vick C.C., Richman J., et al. Surgical site infection prevention: time to move beyond the surgical care improvement program. Ann Surg 2011, 254(3):494-499. [discussion: 499-501].
107. Tillman M., Wehbe-Janek H., Hodges B., et al. Surgical care improvement project and surgical site infections: can integration in the surgical safety checklist improve quality performance and clinical outcomes?. JSurg Res 2013, 184(1):150-156.